Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study-Reference-Cited by-同舟云学术

Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study

Published:2018-01-15 Issue:2 Volume:12 Page:267-278
ISSN:1750-2640
Container-title:Influenza and Other Respiratory Viruses
language:en
Short-container-title:Influenza Other Respi Viruses

Author:

Lina Bruno¹^ORCID,Boucher Charles²,Osterhaus Albert²³,Monto Arnold S.⁴,Schutten Martin²,Whitley Richard J.⁵,Nguyen-Van-Tam Jonathan S.⁶

Affiliation:

1. Lab Virology HCL & CIRI INSERM U1111; Université de Lyon; Lyon France

2. Erasmus MC; Rotterdam The Netherlands

3. Research Institute for Emerging Infections and Zoonoses Veterinary University Hannover; Hannover Germany

4. University of Michigan School of Public Health; Ann Arbor MI USA

5. University of Alabama at Birmingham; Birmingham AL USA

6. Health Protection and Influenza Research Group; University of Nottingham School of Medicine; Nottingham UK

Funder

F. Hoffmann-La Roche

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/irv.12534/fullpdf

Reference28 articles.

1. Antiviral management of seasonal and pandemic influenza;Hayden;J Infect Dis,2006

2. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity;Kim;J Am Chem Soc,1997

3. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern;Bright;Lancet,2005

4. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use;Monto;Antimicrob Agents Chemother,2006

5. Influenza virus susceptibility and resistance to oseltamivir;Aoki;Antivir Ther,2007

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansion;2024-08-17

2. Duration of fever in children infected with influenza A(H1N1)pdm09, A(H3N2) or B virus and treated with baloxavir marboxil, oseltamivir, laninamivir, or zanamivir in Japan during the 2012–2013 and 2019–2020 influenza seasons;Antiviral Research;2024-08

3. Evaluating the Public Health and Health Economic Impacts of Baloxavir Marboxil and Oseltamivir for Influenza Pandemic Control in China: A Cost-Effectiveness Analysis Using a Linked Dynamic Transmission–Economic Evaluation Model;PharmacoEconomics;2024-07-03

4. SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs;Cell Chemical Biology;2024-04

5. Virological and clinical outcomes in outpatients treated with baloxavir or neuraminidase inhibitors for A(H3N2) influenza: A multicenter study of the 2022–2023 season;Antiviral Research;2024-04